Barclays maintains MSTR at Overweight, raises target to $175
Barclays maintained its Overweight rating on MSTR and raised its strategy price target to $175.00 from $160.00, per Benzinga.
Story updates
03:14:32 PM UTC
SquawkNews
Strategy Price Target Raised to $175.00/Share From $160.00 by Barclays